2-oxoquinoline compounds and pharmaceutical uses thereof
CA 2358879 A1 · Owner: Kaya, Tetsudo · Inventors: Kaya, Tetsudo; Inaba, Takashi; Iwamura, Hiroyuki
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
2-Oxoquinoline compounds represented by general formula I or medicinally acceptable salts thereof; and medicinal uses of both (wherein each symbol is as defined in the description). The compounds I and the salts act selectively on cannabinoid receptors, particularly peripheral ones little , have adverse effects on the central nervous system and exhibit excellent , immunosuppressive anti-inflammatory and antiallergic activities thus being , useful as regulators against cannabinoid receptors (particularly peripheral cannabinoid receptors), and immunosuppressive anti-inflammatory and , antiallergic agents.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed December 28, 1999. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended December 28, 2019.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 28, 2021.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.